SCHIPP (Shoes for Self-managing Chronic HIP Pain)
The University of MelbourneDataset description
Demographic, baseline and 6-month follow-up data from the SCHIPP trial. 120 patients aged over 45 years with hip osteoarthritis pain were randomised to either i) Stable supportive shoes or ii) flat flexible shoes. Participants chose from options in their randomly assigned shoe group and were instructed to wear selected shoes at least 6 hours per day for 6 months. The primary outcome was 6-month change in average hip pain on walking in the previous week. All data presented in the results paper (Ann Intern Med - accepted 24/02/2026) available in XLSX format.Date Information
Source Study
Trial name (public)
Purpose:
Phase:
Trial acronym
Not available
Trial ID
ACTRN12621001532897
Funding
University, University of Melbourne
Scientific enquiries
Dr Kade Paterson
Brief Summary
Chronic hip pain is a highly prevalent condition that is largely due to osteoarthritis (OA). Hip OA affects around 40 million people globally and is a leading cause of years lived with disability. With an ageing population and rising rates of obesity, the condition is projected to increase by 58% in Australia over the next decade, leading to substantial societal and health care burden. As hip OA has no cure, advice on self-management of symptoms is recommended as a core treatment component for a .... Read more
Key Inclusion Criteria
a. aged greater than or equal to 45 years; b. activity-related hip joint pain; and c. either no morning hip joint stiffness or stiffness that lasts no longer than 30 minutes; ii) report history of hip pain of at least 3 months duration; iii) report hip pain on most days of the past month; iv) report a minimum hip pain score of 4 out of 10 on an 11-point NRS (terminal descriptors of ‘no pain’ and ‘worst pain possible’) during walking over the previous week.
Key Exclusion Criteria
i) diagnosed in the past 12 months by a health professional as having gluteal tendinopathy, greater trochanteric pain syndrome, referred hip pain from the lumbar spine or femoro-acetabular impingement syndrome; ii) recent hip surgery (past 6 months) or planned surgery in next 6 months; iii) current use of shoe orthoses, customized shoes or brace (on any joint of lower limb); iv) current regular use of high heels, thongs or work boots that would restrict ability to wear allocated trial shoes 6 ho .... Read more
Can healthy volunteers participate?
No
Population
Sample Size 120
Min. age 45 Years
Max. age No limit
Sex Both males and females
Condition category Chronic hip pain
Condition code Musculoskeletal
Intervention
Intervention code Treatment: Other
This comparative effectiveness trial will compare two different classes of footwear. The intervention treatment category is 'stable supportive shoes'. The stable supportive shoes were selected from commercially available footwear, that fulfil previously published criteria for stable supportive shoes (Paterson et al, 2017,Osteoarthritis & Cartilage). These criteria are: 1) heel height of greater than 30mm; 2) shoe pitch of greater than 10mm; 3) presence of arch support or motion control; 4) have .... Read more
Comparison
Control group Active
The comparator treatment category is 'flat flexible shoes' The flat flexible shoes were selected from commercially available footwear, that fulfill previously published criteria for flat flexible shoes (Paterson et al, 2017, Osteoarthritis & Cartilage). These criteria are: 1) heel height of less than 15mm; 2) shoe pitch of less than 10mm; 3) absence of arch support or motion control; 4) have "minimal" sole rigidity (Barton et al. 2009, J Foot Ankle Res); and 5) weigh 200g or less (+/-10%). Measu .... Read more
Outcomes
Outcome: Severity of hip pain during walking Scored on an 11-point numerical rating scale (NRS) for average overall hip pain on walking in the last week. Ranges from 0 to 10; where 0=no pain and 10=worst pain possible.Timepoint: Baseline and 6 months after randomisation
Will the study consider sharing individual participant data?
Yes
Who can request access to individual participant data?
Available to researchers by request on a case-by-case basis at the discretion of the principal researcher
Are there any conditions for requesting access to individual participant data?
-
What individual participant data might be shared?
Individual participant data not covered above
Deidentified individual participant data of published results only
What types of analyses could be done with individual participant data?
Meta analyses
Are there extra considerations when requesting access to individual participant data?
No
When can request for individual data be made (start and end dates)?
From: Immediately following publication to 15 years following publication
To: -